ATB Therapeutics

Belgium
Baileux, Wallonia, Belgium, 6900

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
5
Total equity funding
$63M
Last funding
Series A / $57.2M / 2024-11-18
Last equity funding
Series A / $57.2M
Investors
11
Lead investors
5
Articles
16

Founders and investors

Lead investors

EQT Life SciencesFinancière Spin-Off LuxembourgeoiseFournier-MajoieMRL Ventures FundWalloon

Investors

EQT Life SciencesMRL Ventures FundSambrinvestSFPIMV-Bio Ventures